1. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies. Issue 12 (December 2014) Authors: Marquez, Rafael; Hantel, Andrew; Lorenz, Rachelle; Neistadt, Barbara; Wong, Jerry; Churpek, Jane E.; Mardini, Nameer Al; Shaukat, Ismael; Gurbuxani, Sandeep; Miller, Jonathan L.; Godley, Lucy A. Journal: Leukemia & lymphoma Issue: Volume 55:Issue 12(2014:Dec.) Page Start: 2945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Process Framework for Ethically Deploying Artificial Intelligence in Oncology. Issue 34 (1st December 2022) Authors: Hantel, Andrew; Clancy, Dillon D.; Kehl, Kenneth L.; Marron, Jonathan M.; Van Allen, Eliezer M.; Abel, Gregory A. Journal: Journal of clinical oncology Issue: Volume 40:Issue 34(2022) Page Start: 3907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia. Issue 9 (2nd September 2017) Authors: Khan, Niloufer; Hantel, Andrew; Knoebel, Randall W.; Artz, Andrew; Larson, Richard A.; Godley, Lucy A.; Thirman, Michael J.; Liu, Hongtao; Churpek, Jane E.; King, Darren; Odenike, Olatoyosi; Stock, Wendy Journal: Leukemia & lymphoma Issue: Volume 58:Issue 9(2017) Page Start: 2127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ethics Consultation in Oncology: The Search for Quality in Quantity. Issue 9 (10th September 2022) Authors: Marron, Jonathan M.; Hantel, Andrew; Abel, Gregory A.; Peppercorn, Jeffrey M. Journal: JCO oncology practice Issue: Volume 18:Issue 9(2022) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Issue 6 (25th November 2020) Authors: Hantel, Andrew; DuMontier, Clark; Odejide, Oreofe O.; Luskin, Marlise R.; Sperling, Adam S.; Hshieh, Tammy; Chen, Richard; Soiffer, Robert; Driver, Jane A.; Abel, Gregory A. Journal: Cancer Issue: Volume 127:Issue 6(2021) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Model solutions for ethical allocation during cancer medicine shortages. Issue 4 (April 2021) Authors: Hantel, Andrew; Peppercorn, Jeff; Abel, Gregory A Journal: Lancet Issue: Volume 8:Issue 4(2021) Page Start: e246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Peri‐transfusion quality‐of‐life assessment for patients with myelodysplastic syndromes. Issue 10 (12th July 2021) Authors: Abel, Gregory A.; Klepin, Heidi D.; Magnavita, Emily S.; Jaung, Tim; Lu, Wen; Shallis, Rory M.; Hantel, Andrew; Bahl, Nupur E.; Dellinger‐Johnson, Rebecca; Winer, Eric S.; Zeidan, Amer M. Journal: Transfusion Issue: Volume 61:Issue 10(2021) Page Start: 2830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Practical allocation system for the distribution of specialised care during cellular therapy access scarcity. Issue 8 (19th June 2019) Authors: Hantel, Andrew; Abel, Gregory A; Siegler, Mark Journal: Journal of medical ethics Issue: Volume 45:Issue 8(2019) Page Start: 532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab. Issue 1 (16th July 2018) Authors: Hantel, Andrew; Gabster, Brooke; Cheng, Jason X.; Golomb, Harvey; Gajewski, Thomas F. Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗